Fundraising Fox
Alex Morgan
InvestorPartner at Khosla Ventures
Palo Alto, California
Writes $500K – $50M checks · typically $25M
Find your path to Alex
Sign up to see every warm intro you have to Alex
- Paths you didn't know you had: your email and LinkedIn already hold routes to Alex. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Alexander Morgan, an MD/PhD physician-scientist with 25 years at the AI–biotech–healthcare intersection, oversees biotech and healthcare investing with an AI/ML emphasis and is one of the most active neurotech investors.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechClimate TechData & InfrastructureDigital HealthEnterprise SoftwareHealthtech
Beyond investing
- Education
- Studied at Brandeis University (Undergraduate degree, Physics) Studied at Tufts University (MS, Biology) Studied at Stanford University (MS, Biomedical Informatics)
- Communities
- Morgan served as co-manager of the volunteer-staffed Arbor Free Clinic in Menlo Park, where he also worked as head of IT and helped develop and deploy their electronic medical records system. Morgan is committed to improving access to healthcare for underserved communities and to advancing diversity in STEM fields, including technology entrepreneurship.
- More
- Morgan completed his MD and PhD dissertation on machine learning methods in precision medicine under the supervision of Atul Butte at Stanford. Morgan's postdoctoral fellowship in biochemistry and genetics was conducted with Ronald W. Davis at the Stanford Genome Technology Center.
From published sources — common ground for a warm intro.
Deals · 6
Faeth TherapeuticsBoard seat
via Khosla Ventures · filed Jan 2026 · $25M raise
Gather Health Primary Care, Inc.Board seat
via Khosla Ventures · filed Jul 2025 · $25M raise
VivodyneBoard seat
via Khosla Ventures · filed Jun 2025 · $77.7M raise
Viome Life SciencesBoard seat
via Khosla Ventures · filed Aug 2024 · $30M raise
SynchronBoard seat
via Khosla Ventures · filed Dec 2022 · $86M raise
PrellisBoard seat
via Khosla Ventures · filed Jul 2022 · $35M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Deep GenomicsHeartVistaHello HeartOpentrons
Investor
CHARM TherapeuticsCirculateClair HealthDocbotEncellinFlow NeuroscienceGather HealthInflammatix, Inc.KariusKarma BiotechnologiesLoyalMenten AIOchre BioRejuvenation TechnologiesRubedo Life SciencesTurn.bio
Sources: curated public sources · SEC Form D filings.
Colleagues at Khosla Ventures
Network17
▶5 more connections
Chiara CastelliChris GibsonDavid WeidenEce Erdagoz WyrickEthan Choi
Investors connected to Alex in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alex Morgan?
- Alexander Morgan, an MD/PhD physician-scientist with 25 years at the AI–biotech–healthcare intersection, oversees biotech and healthcare investing with an AI/ML emphasis and is one of the most active neurotech investors.
- Where does Alex Morgan work?
- Alex Morgan is Partner at Khosla Ventures.
- What does Alex Morgan invest in?
- Alex Morgan invests in AI & Machine Learning, Biotech, Climate Tech, Data & Infrastructure, Digital Health, Enterprise Software, Healthtech.
- What check size does Alex Morgan write?
- Alex Morgan typically writes checks of $500K – $50M.
- What boards does Alex Morgan sit on?
- Alex Morgan holds tracked board seats at Deep Genomics, Faeth Therapeutics, Gather Health Primary Care, Inc., HeartVista, Hello Heart, Opentrons, Prellis, Synchron, Viome Life Sciences, Vivodyne.
- What companies has Alex Morgan invested in?
- Investments tracked here include CHARM Therapeutics, Circulate, Clair Health, Docbot, Encellin, Faeth Therapeutics, Flow Neuroscience, Gather Health, Inflammatix, Inc., Karius, Karma Biotechnologies, Loyal, and 6 more.
About this profile. Compiled from public sources — Khosla Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights